Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1993 1
1994 1
1995 1
1996 2
1997 1
1998 1
2000 2
2002 2
2004 1
2007 3
2008 7
2009 3
2010 2
2011 3
2012 6
2013 1
2017 1
2019 1
2020 3
2021 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Cancer patient perspective in the arena of COVID-19 pandemic.
Ballatore Z, Merloni F, Ranallo N, Bastianelli L, Vitarelli F, Cantini L, Ricci G, Ferretti B, Alessandroni P, Del Prete M, Chiorrini S, Safi M, Ficarelli R, Benedetti G, Faloppi L, Marcellini M, Stoico R, Berardi R. Ballatore Z, et al. Among authors: alessandroni p. Psychooncology. 2022 Jan;31(1):39-45. doi: 10.1002/pon.5774. Epub 2021 Aug 19. Psychooncology. 2022. PMID: 34315188 Free PMC article.
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
Catalano V, Graziano F, Santini D, D'Emidio S, Baldelli AM, Rossi D, Vincenzi B, Giordani P, Alessandroni P, Testa E, Tonini G, Catalano G. Catalano V, et al. Among authors: alessandroni p. Br J Cancer. 2008 Nov 4;99(9):1402-7. doi: 10.1038/sj.bjc.6604732. Br J Cancer. 2008. PMID: 18971936 Free PMC article.
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.
Ruzzo A, Graziano F, Loupakis F, Santini D, Catalano V, Bisonni R, Ficarelli R, Fontana A, Andreoni F, Falcone A, Canestrari E, Tonini G, Mari D, Lippe P, Pizzagalli F, Schiavon G, Alessandroni P, Giustini L, Maltese P, Testa E, Menichetti ET, Magnani M. Ruzzo A, et al. Among authors: alessandroni p. Pharmacogenomics J. 2008 Aug;8(4):278-88. doi: 10.1038/sj.tpj.6500463. Epub 2007 Jun 5. Pharmacogenomics J. 2008. PMID: 17549067
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.
Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P, Spoto C, Zingaretti C, Sisti V, Alessandroni P, Giordani P, Cicetti A, D'Emidio S, Morini S, Ruzzo A, Magnani M, Tonini G, Rabitti C, Graziano F. Perrone G, et al. Among authors: alessandroni p. Eur J Cancer. 2008 Sep;44(13):1875-82. doi: 10.1016/j.ejca.2008.05.017. Epub 2008 Jul 9. Eur J Cancer. 2008. PMID: 18617393
[Xe International Congress of the Société de pathologie exotique, 8-9 November 2017, Haiphong (Vietnam) - Surgery Access in Tropical Areas].
Buisson Y, Guyon P, Buisson Y, Osinki N, Tamames C, Leconte J, Jarry M, Robert J, Dumurgier C, Choua O, Ahmat MO, Moussa KM, Sabe D, Telniaret A, Rabo AM, Kitoko N, Allatombaye B, Bunn D, Hong Dao N, Huy LD, Bich Ngoc HL, Tram LH, Van Khoi T, Van Thuc P, Van Linh P, Kourouma K, Gerald FT, Kourouma K, Saibou PO, Ngunyi GC, Wombe B, Alessandroni P, Andrei R, Delmont J, Gasiglia C, Haï VV, Heng M, Heng T, Khampho C, Mekhalfa D, Marcaggi S, Pimontipa M, Plotton JR, The Ngo NA, Vilayphone T, Duong TX, Hoa NL, Pays JF, Buchy P, Goujon C, Bouchaud O, Consigny PH, de Gentile L, D'Ortenzio E, Gautret P, Sorge F, Strady C, Pichard E, Haddar C, Bégaud E, Yuh MY, Law EL, Germani Y, Bouchaud O, Houze S; groupe d’étude MalaRia; Chandenier J, Jannin J, Solano P, Quick I, Debre P, Guyon P, Ensaf A, Bourée P, Fabre-Teste B, El Mouden M, Soula G. Buisson Y, et al. Among authors: alessandroni p. Bull Soc Pathol Exot. 2017 Dec;110(5):353-354. doi: 10.1007/s13149-017-0586-6. Bull Soc Pathol Exot. 2017. PMID: 29299881 French. No abstract available.
Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted.
Rossi D, Lippe P, Rocchi MBL, Sarti D, Catalano V, Graziano F, Giordani P, Baldelli A, Fedeli SL, Imperatori L, Laici G, Cappelletti C, Tamburrano T, Bracci R, Alessandroni P. Rossi D, et al. Among authors: alessandroni p. In Vivo. 2020 Sep-Oct;34(5):2687-2691. doi: 10.21873/invivo.12088. In Vivo. 2020. PMID: 32871800 Free PMC article. Clinical Trial.
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.
Catalano V, Loupakis F, Graziano F, Bisonni R, Torresi U, Vincenzi B, Mari D, Giordani P, Alessandroni P, Salvatore L, Fornaro L, Santini D, Baldelli AM, Rossi D, Giustini L, Silva RR, Falcone A, D'Emidio S, Rocchi M, Luzi Fedeli S. Catalano V, et al. Among authors: alessandroni p. Ann Oncol. 2012 Jan;23(1):135-141. doi: 10.1093/annonc/mdr062. Epub 2011 Apr 29. Ann Oncol. 2012. PMID: 21531784 Free article.
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
Catalano V, Bergamo F, Cremolini C, Vincenzi B, Negri F, Giordani P, Alessandroni P, Intini R, Stragliotto S, Rossini D, Borelli B, Santini D, Sarti D, Rocchi MBL, Lonardi S, Falcone A, Zagonel V, Mattioli R, Graziano F. Catalano V, et al. Among authors: alessandroni p. J Cancer Res Clin Oncol. 2020 Feb;146(2):493-501. doi: 10.1007/s00432-019-03077-w. Epub 2019 Nov 6. J Cancer Res Clin Oncol. 2020. PMID: 31691872
HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer.
Catalano V, Mellone P, d'Avino A, Shridhar V, Staccioli MP, Graziano F, Giordani P, Rossi D, Baldelli AM, Alessandroni P, Santini D, Lorenzon L, Testa E, D'Emidio S, De Nictolis M, Muretto P, Fedeli SL, Baldi A. Catalano V, et al. Among authors: alessandroni p. Histopathology. 2011 Apr;58(5):669-78. doi: 10.1111/j.1365-2559.2011.03818.x. Epub 2011 Mar 30. Histopathology. 2011. PMID: 21447133 Clinical Trial.
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy.
Graziano F, Fischer NW, Bagaloni I, Di Bartolomeo M, Lonardi S, Vincenzi B, Perrone G, Fornaro L, Ongaro E, Aprile G, Bisonni R, Prisciandaro M, Malkin D, Gariépy J, Fassan M, Loupakis F, Sarti D, Del Prete M, Catalano V, Alessandroni P, Magnani M, Ruzzo A. Graziano F, et al. Among authors: alessandroni p. Cancers (Basel). 2020 Jul 24;12(8):2049. doi: 10.3390/cancers12082049. Cancers (Basel). 2020. PMID: 32722340 Free PMC article.
39 results